On the basis of the above binding affinity assessment in vitro, we tested the binding capability of LDP-TIMP2 and LDP to human cancer specimens through tissue microarray of esophageal squamous cell carcinoma and matched adjacent tissues. This evidence concerns the gene CPQ and esophageal squamous cell carcinoma.